Suchergebnisse - "Vaccines, Inactivated"

PubPharm (9.826)

1

Production of a new tetravalent vaccine targeting fimbriae and enterotoxin of enterotoxigenic Escherichia coli

enthalten in: Canadian journal of veterinary research = Revue canadienne de recherche veterinaire | 2024

von Xu, C. | She, Y. | Fu, F. | +1

2

Novel OPV is Still not the Right Tool for Polio Eradication

enthalten in: Indian pediatrics | 2024

von John, T. | Dharmapalan, D. | Steinglass, R. | +1

3

Modeling Poliovirus Transmission and Responses in New York State

enthalten in: The Journal of infectious diseases | 2024

von Thompson, K. | Kalkowska, D. | Routh, J. | +7

4

The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines

enthalten in: The New England journal of medicine | 2024

von Monto, A. | Zambon, M. | Weir, J.

5

Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge

enthalten in: Vaccine | 2024

von Wu, J. | Jiang, L. | Shao, Q. | +6

6

Estradiol mediates greater germinal center responses to influenza vaccination in female than male mice

enthalten in: mBio | 2024

von Dhakal, S. | Park, H. | Seddu, K. | +7

UpdateOf: bioRxiv. 2023 Nov 27;:. - PMID 38077071

7

SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients

enthalten in: mBio | 2024

von Chen, Y. | Zhao, T. | Chen, L. | +10

8

Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity

enthalten in: Virology | 2024

von Zheng, X. | Yang, R. | Zhao, Y. | +15

9

Immunogenicity of Enhanced Influenza Vaccines Against Mismatched Influenza Strains in Older Adults : A Review of Randomized Controlled Trials

enthalten in: Influenza and other respiratory viruses | 2024

von Youhanna, J. | Tran, V. | Hyer, R. | +1

10

Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia : an observational cohort study

enthalten in: The Lancet. Infectious diseases | 2024

von Bashorun, A. | Kotei, L. | Jawla, O. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[983]